The results of the cross-sectional analyses were replicated in longitudinal analyses, where preexisting long-lasting T2DM had a significant predictive value on most cognitive biomarkers at baseline (particularly Hippocampus volume, total Tau, and NfL), despite excluding those priorly diagnosed with cognitive impairment. Here, MAPT is linked to Cognitive impairment.